Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis.
Filetti M, Lombardi P, Giusti R, Falcone R, Scotte F, Giannarelli D, Carcagnì A, Altamura V, Scambia G, Daniele G. Filetti M, et al. Among authors: altamura v. Cancer Treat Rev. 2023 Apr;115:102512. doi: 10.1016/j.ctrv.2023.102512. Epub 2023 Jan 21. Cancer Treat Rev. 2023. PMID: 36774658 Free article.
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 Years.
Falcone R, Lombardi P, Filetti M, Duranti S, Pietragalla A, Fabi A, Lorusso D, Altamura V, Paroni Sterbini F, Scambia G, Daniele G. Falcone R, et al. Among authors: altamura v. Cancers (Basel). 2022 Feb 11;14(4):889. doi: 10.3390/cancers14040889. Cancers (Basel). 2022. PMID: 35205637 Free PMC article.
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers.
Falcone R, Filetti M, Lombardi P, Altamura V, Paroni Sterbini F, Scambia G, Daniele G. Falcone R, et al. Among authors: altamura v. Explor Target Antitumor Ther. 2023;4(4):716-726. doi: 10.37349/etat.2023.00163. Epub 2023 Aug 31. Explor Target Antitumor Ther. 2023. PMID: 37711591 Free PMC article.
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis.
Filetti M, Lombardi P, Falcone R, Giusti R, Giannarelli D, Carcagnì A, Altamura V, Scambia G, Daniele G. Filetti M, et al. Among authors: altamura v. Explor Target Antitumor Ther. 2023;4(6):1136-1144. doi: 10.37349/etat.2023.00187. Epub 2023 Dec 1. Explor Target Antitumor Ther. 2023. PMID: 38213541 Free PMC article.
[Multidistrict atherosclerotic disease: epidemiological and clinical framework].
Di Fusco SA, Abrignani MG, Amico AF, Lucà F, Mureddu GF, Ceravolo R, Temporelli PL, Acerbo V, Altamura V, Baccino D, Binaghi G, Bugani G, Cesaro A, Ciccirillo F, Cocozza S, D'Errigo P, Di Martino M, Di Nora C, Fileti L, Lopriore V, Maloberti A, Monitillo F, Gulizia MM, Grimaldi M, Gabrielli D, Oliva F, Colivicchi F. Di Fusco SA, et al. Among authors: altamura v. G Ital Cardiol (Rome). 2024 Apr;25(4):239-251. doi: 10.1714/4244.42205. G Ital Cardiol (Rome). 2024. PMID: 38526360 Review. Italian.
[ANMCO Position paper: Evidence and practical indications for the use of low-dose rivaroxaban in stable coronary artery disease and peripheral artery disease].
Di Fusco SA, Rizzello V, Scicchitano P, Lucà F, Altamura V, Bianco M, De Luca L, Valente S, Riccio C, Caldarola P, Cipriani M, Francese GM, Navazio A, Nardi F, Ceravolo R, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F. Di Fusco SA, et al. Among authors: altamura v. G Ital Cardiol (Rome). 2022 Dec;23(12):967-976. doi: 10.1714/3913.38965. G Ital Cardiol (Rome). 2022. PMID: 36504216 Italian.
27 results